ELISAs for Alzheimer’s disease
Determination of the biomarkers amyloid beta (Aβ) 1-40 and 1-42 and total tau in cerebrospinal fluid (CSF) is increasingly important for the diagnosis of Alzheimer’s disease, especially in the early stages. Measurement of these highly sensitive and specific analytes aids the classification and prognosis of dementia. Patients with Alzheimer’s disease show a significantly decreased level […]
